Amedisys Inc (AMED)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	496,935	467,227	426,544	405,557	388,961	388,780	394,869	392,485	356,684	432,882	390,965	380,450	361,984	411,250	449,540	468,128	350,554	299,519	275,785	271,731
Total current liabilities	US$ in thousands	473,721	468,119	462,401	353,050	355,529	367,200	427,372	380,154	374,282	454,349	449,223	456,082	456,337	437,496	442,048	316,106	326,943	314,653	313,007	297,377
Current ratio		1.05	1.00	0.92	1.15	1.09	1.06	0.92	1.03	0.95	0.95	0.87	0.83	0.79	0.94	1.02	1.48	1.07	0.95	0.88	0.91

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $496,935K ÷ $473,721K
= 1.05

The current ratio of Amedisys Inc. has shown some fluctuations over the past eight quarters. The ratio indicates the company's ability to cover its short-term liabilities with its short-term assets. A current ratio below 1.0 may signal liquidity issues, while a ratio above 1.0 typically suggests the company is able to meet its short-term obligations.

In Q4 2023, the current ratio was 1.05, indicating that Amedisys had $1.05 in current assets for every $1.00 in current liabilities. This suggests a healthy liquidity position.

In Q3 2023, the current ratio was 1.00, indicating a balance between current assets and current liabilities.

In Q2 2023, the current ratio decreased to 0.92, which may raise concerns about the company's ability to cover its short-term obligations. However, it improved in Q1 2023 to 1.15, indicating a better liquidity position.

Comparing the latest ratio to the same quarter in the previous year, we see a slight increase from Q4 2022 (1.09) to Q4 2023 (1.05), which is a positive sign. However, there has been some variability in the interim quarters.

Overall, while the current ratio has fluctuated, Amedisys has generally maintained a current ratio above 1.0 in recent quarters, indicating that the company generally has sufficient current assets to cover its current liabilities. Investors and stakeholders should continue to monitor the trend to ensure the company's liquidity remains stable.